Medical Condition News

RSS

Women with low serum adiponectin levels more likely to develop asthma

Low serum adiponectin levels predict an increased future risk for developing asthma in middle-aged women, particularly among smokers, according to a new study.

23 Mar 2012

Immediate skull reconstruction aggravates brain damage in TBI model

Immediate skull reconstruction following trauma that penetrates or creates an indentation in the skull can aggravate brain damage inflicted by the initial injury, a study by a University of South Florida research team reports.

23 Mar 2012

Employers target lifestyle habits to improve health of employees: Survey

Organizations in the Chicago area report an increase of health-improvement and wellness programs according to a survey conducted in September 2011 by Aon Hewitt in partnership with Rush Health. The survey results will be released at the 9th annual Employer Symposium at Rush University Medical Center in Chicago on Thursday, March 22.

23 Mar 2012

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

23 Mar 2012

Nearly three in five Kentuckians believe pain is just a part of life

New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.

23 Mar 2012

Cardiff team receives European grants to develop 'RealTCut' surgical simulation

Highly realistic surgical simulation which reduces patient risk has become the 100th Cardiff University project to win an award under the European Union's prime research funding scheme, the Seventh Framework Programme.

23 Mar 2012

Scripps scientists generate synthetic memory trace

Scripps Research Institute scientists and their colleagues have successfully harnessed neurons in mouse brains, allowing them to at least partially control a specific memory. Though just an initial step, the researchers hope such work will eventually lead to better understanding of how memories form in the brain, and possibly even to ways to weaken harmful thoughts for those with conditions such as schizophrenia and post traumatic stress disorder.

23 Mar 2012

IBM, MSKCC partner to develop decision support tool for oncologists

Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices.

23 Mar 2012

TAS2R38 and CD36 gene may play a role in fat perception

While high-fat foods are thought to be of universal appeal, there is actually a lot of variation in the extent to which people like and consume fat. A new study in the March issue of the Journal of Food Science, published by the Institute of Food Technologists, reported that two specific genes, may play a role in some people's ability to taste and enjoy dietary fat.

23 Mar 2012

Boston Scientific's WallFlex Stent technology now available for interventional radiologists

Boston Scientific Corporation announces the U.S. and international launch of the WallFlex Biliary Transhepatic Stent System.

23 Mar 2012

Blocking PFKFB4 enzyme could prevent growth of prostate cancer cells

Cancer Research UK scientists have discovered how blocking a key enzyme, which helps convert glucose into energy, could provide a new way to kill prostate cancer cells, according to a study published in the journal Cancer Discovery.

23 Mar 2012

HCC patients have reduced risk of waitlist mortality

New research shows increasing disparity in mortality among candidates with and without hepatocellular carcinoma (HCC) who are on the waiting list for liver transplantation. The study available in the April issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, found that liver cancer patients are less likely to die on the wait list than non-HCC candidates, prompting transplantation specialists to suggest a reevaluation of current allotment criteria for those with HCC.

23 Mar 2012

tAI could predict sensitivity to chemotherapy in patients with triple-negative breast cancer

Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.

23 Mar 2012

Study provides important clue in type 1 diabetes

In type 1 diabetes (T1D), pancreatic beta cells die from a misguided autoimmune attack, but how and why that happens is still unclear. Now, JDRF-funded scientists from the Indiana University School of Medicine have found that a specific type of cellular stress takes place in pancreatic beta cells before the onset of T1D, and that this stress response in the beta cell may in fact help ignite the autoimmune attack.

23 Mar 2012

PFKFB4 gene leads to excessive growth of prostate cancer cells

Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.

23 Mar 2012

Verapamil drug may reverse diabetes-related death of pancreatic beta cells

A common high-blood-pressure medication appears to reverse the diabetes-related death of pancreatic beta cells, according to a University of Alabama at Birmingham study published today in the journal Diabetes.

23 Mar 2012

Study identifies abnormal brain gene expression patterns in autism

A study led by Eric Courchesne, PhD, director of the Autism Center of Excellence at the University of California, San Diego School of Medicine has, for the first time, identified in young autism patients genetic mechanisms involved in abnormal early brain development and overgrowth that occurs in the disorder. The findings suggest novel genetic and molecular targets that could lead to discoveries of new prevention strategies and treatment for the disorder.

23 Mar 2012

Researcher examines factors that influence injury rate among soccer players

All soccer players and fans know that it is better to win than to lose. Yet the fact that victory also means less risk of injury is not as obvious. New findings from researchers in sports medicine at Linköping University have aroused great interest among Europe's elite soccer teams.

23 Mar 2012

Hyperion acquires worldwide rights to Ucyclyd's Ravicti

Hyperion Therapeutics, Inc. today announced that it has acquired worldwide rights to the investigational drug Ravicti from Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation.

23 Mar 2012

No added benefit from retigabine therapy in adults with epileptic seizures

The drug retigabine was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy.

23 Mar 2012